LATENT TUBERCULOSIS
Clinical trials for LATENT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new LATENT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for LATENT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-month TB pill regimen tested for kidney transplant hopefuls
Disease control OngoingThis study tests whether a 1-month course of three medicines (isoniazid, rifapentine, and vitamin B6) is safe and easy to complete for people with end-stage kidney disease who are waiting for a kidney transplant and have latent (inactive) tuberculosis. About 25 adults will take t…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE4 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Can a 3-Minute video stop TB? trial tests simple fix for treatment dropouts
Disease control OngoingThis study is testing if a simple, 3-minute educational video can help more people finish their full course of medication for latent tuberculosis (LTBI). Many people start this treatment but don't complete it, which is a problem for public health. Researchers are comparing people…
Matched conditions: LATENT TUBERCULOSIS
Phase: NA • Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Apr 16, 2026 13:01 UTC